IRAK3 and essential thrombocythemia: In the case of ET, experiments blocking HIFα –either by siRNA or using inhibitors of its expression– have shown that key features of ET, including IRAK-M expression, increased phagocytosis and tissue remodelling in the context of sepsis (32, 36) and COVID-19 (37), are reduced or even disappear.